SARS-CoV-2 infections in melanoma patients treated with PD-1-inhibitors- a survey of the German ADOREG melanoma registry
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Dear editors, Currently, a second dramatic upsurge of SARS-CoV-2 infection rates is observed across Europe and there is an urgent need to clarify the imminent risk for our melanoma patients under immune checkpoint inhibition (ICI). To this aim we reviewed the clinical course of disease for all patients included in the registry of the German working group of dermato-oncology (ADOreg, www.hautkrebsregister.de) database with confirmed SARS-CoV-2 infection. ICI treatment for melanoma might influence the clinical course of a SARS-CoV-2-infection in different ways (...)
European Journal of Cancer , éditorial en libre accès, 2019